- Slow acute season in India
- Lower South Africa revenue due to strategic decisions
- Elevated freight costs in the second half of the year
J. B. Chemicals & Pharmaceuticals Limited
Greenhouse gas emissions & sustainability report data
In its 2023-24 reporting, J. B. Chemicals & Pharmaceuticals Limited disclosed greenhouse gas emissions of 46.0K tCO2e/year (Scope 1 & 2). By scope: Scope 1: 8.6K tCO2e/year; Scope 2: 37.5K tCO2e/year; Scope 3: 188.6K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
46.0K tCO2e/year (Scope 1 & 2)
2023-24
Renewable Energy
13%
of total energy
Water Usage
309.1K kiloliters/year
2023-24
Waste
2.7K metric tonnes/year
2023-24
📊 Emissions by Scope (2023-24)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 8.6K tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 37.5K tCO2e/year |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 188.6K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- 16.67% reduction in Scope 1 and Scope 2 emissions
- 9% reduction in total energy consumption
- Zero Liquid Discharge in all manufacturing plants
🎯 Climate & Sustainability Targets
📅 Medium-term
- Carbon neutral in direct operations (Scope 1 and 2 emissions) by FY 2032-33
- To meet 50% of energy demand from renewable energy by FY 2026-27 and 100% by FY 2032-33
🌱 ESG Focus Areas
EnvironmentalSocialGovernance